LOADING
Comparing UnitedHealth Group (UNH) and Johnson & Johnson (JNJ), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | UNH | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $382.8B | $617.8B |
| P/E Ratio | 31.6 | 29.7 |
| Forward P/E | 21.3 | 22.0 |
| PEG Ratio | 1.30 | 4.22 |
| EPS | $13.32 | $8.64 |
| Revenue Growth (YoY) | 0.4% | 6.6% |
| Profit Margin | 3.1% | 21.5% |
| Return on Equity | 14.1% | 25.7% |
| Dividend Yield | 1.05% | 2.05% |
| Beta | 0.63 | 0.23 |
| 52-Week High | $461.62 | $274.90 |
| 52-Week Low | $230.77 | $162.56 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.